Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
<p>Abstract</p> <p>Background</p> <p>Treatment guidelines recommend LDL-C as the primary target of therapy in patients with hypercholesterolemia. Moreover, combination therapies with lipid-lowering drugs that have different mechanisms of action are recommended when it i...
| Những tác giả chính: | , , , , |
|---|---|
| Định dạng: | Bài viết |
| Ngôn ngữ: | English |
| Được phát hành: |
BMC
2010-07-01
|
| Loạt: | Lipids in Health and Disease |
| Truy cập trực tuyến: | http://www.lipidworld.com/content/9/1/80 |